Safety and efficacy of therapeutic monoclonal antibodies in clinical therapy
- 30 September 1993
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 14 (9), 421-425
- https://doi.org/10.1016/0167-5699(93)90243-e
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Humanized antibodiesImmunology Today, 1993
- Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal AntibodiesImmunological Reviews, 1992
- CORTICOSTEROID INHIBITION OF THE OKT3-INDUCED CYTOKINE-RELATED SYNDROMETransplantation, 1991
- Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.Journal of Clinical Oncology, 1989
- REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1HThe Lancet, 1988
- Immunotherapy of the Nonobese Diabetic Mouse: Treatment with an Antibody to T-Helper LymphocytesScience, 1988
- Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.The Journal of Immunology, 1986
- Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphyImmunology Today, 1981
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975